Cas:57602-02-5 Bromo-PEG4-bromide manufacturer & supplier

Chemical Name:Bromo-PEG4-bromide

CAS.NO:57602-02-5

Synonyms:3,6,9,12-Tetraoxatetradecane, 1,14-dibromo-;1,14-Dibromo-3,6,9,12-tetraoxatetradecane;1,2-bis[2-(2-bromoethoxy)ethoxy]ethane

Molecular Formula:C₁₀H₂₀Br₂O₄

Molecular Weight:364.071

HS Code:2909199090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:373.2±32.0 °C at 760 mmHg

Density:1.5±0.1 g/cm3

Index of Refraction:1.489

PSA:36.92000

Exact Mass:361.972809

LogP:0.80

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3,6,9,12-Tetraoxatetradecane, 1,14-dibromo- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,2-bis[2-(2-bromoethoxy)ethoxy]ethane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,2-bis[2-(2-bromoethoxy)ethoxy]ethane Use and application,3,6,9,12-Tetraoxatetradecane, 1,14-dibromo- technical grade,usp/ep/jp grade.

Related News: Cost: Hedge prices of thick product lines + self-produced intermediates fluctuate, and sufficient supply of upstream raw materials can significantly promote the production of APIs. Bromo-PEG4-bromide manufacturer In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum. Bromo-PEG4-bromide supplier Alira is one of many in the CRO space to ink deals in recent months. Altasciences acquired preclinical CRO Calvert Laboratories in May, weeks after itself being bought out by Novo Holdings, and a few months after buying early-stage CRO WCCT Global. Bromo-PEG4-bromide vendor Capacity: the bottleneck of business growth, expanding capacity and increasing utilization become a trend. Capacity is the core factor that determines the supply capacity of API companies. Insufficient capacity will cause companies to selectively complete orders and produce varieties, limiting the expansion of API products and market development. Bromo-PEG4-bromide factory Alira is one of many in the CRO space to ink deals in recent months. Altasciences acquired preclinical CRO Calvert Laboratories in May, weeks after itself being bought out by Novo Holdings, and a few months after buying early-stage CRO WCCT Global.